| HOME >> MEDICINE >> TECHNOLOGY |
THOUSAND OAKS, Calif., Jan. 31, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will hold its Business Review Meeting on Thursday, Feb. 7, 2013, at the Mandarin Oriental Hotel, 80 Columbus Circle, New York City, beginning at 8 a.m. Eastern Standard Time. In the meeting, Robert A. Bradway , chairman and chief executive officer, Sean E. Harper , M.D., executive vice president, Research and Development, Anthony C. Hooper , executive vice president, Global Commercial Operations, and Jonathan M. Peacock , executive vice president and chief financial officer, will discuss the Company's plans to manage our diversified portfolio of in-market products, a strong emerging pipeline, and other initiatives that will drive future growth.
The webcast will be available to members of the news media, investors and the general public, and is expected to last approximately four hours.
The webcast of the meeting, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability, and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay at least 30 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have change
'/>"/>
| SOURCE Amgen Copyright©2012 PR Newswire. All rights reserved |